Font Size
-
+

Agency holds pharmacy stakeholder meetings about reimbursement options

On February 1, 2016, the Centers for Medicare and Medicaid Services (CMS) published 42 CFR, Part 447: Medicaid Program Covered Outpatient Drugs with final comments (CMS-2345-FC). This rule addresses regulations that pertain to reimbursement for covered outpatient drugs in the Medicaid program. The document is available online at http://federalregister.gov/a/2016-01274.

On March 8, 2016, the Division of Medicaid (DOM) held an initial Pharmacy Stakeholder meeting for the purpose of reviewing CMS-2345-FC.

On May 19, 2016, Division of Medicaid (DOM) held a Pharmacy Stakeholder Meeting to provide viable reimbursement options to pharmacy stakeholders.

The invited organizations included:

  • Independent Nursing Home Association (INHA)
  • Magnolia Health
  • MS Association of Community Mental Health Centers (MACMHC)
  • MS Hospital Association (MHA)
  • MS Independent Pharmacies Association (MIPA)
  • MS Pharmacists Association (MPhA)
  • MS Primary Health Care Association (MHCA)
  • MS Society of Health-Systems Pharmacists (MSHP)
  • MS State Medical Association (MSMA)
  • National Association of Chain Drug Stores (NACDS)
  • United Healthcare

In June 2016, DOM will be hosting another Pharmacy Stakeholder Meeting for stakeholders to submit questions and/or comments regarding the reimbursement options.  Please send in send your questions and/or comments to your respective organization for submission to DOM.

On June 28, 2016, Division of Medicaid (DOM) held a Pharmacy Stakeholder Meeting to address questions and/or comments from pharmacy stakeholders regarding viable reimbursement options for covered outpatient drugs in the Medicaid program.

On August 2, 2016, Division of Medicaid (DOM) held a Pharmacy Stakeholder Meeting to begin discussions regarding reimbursement options for specialty drugs in the Medicaid program.